{"description":"The safety set consisted of all subjects who received at least one dose of AFM13 and had at least one post-baseline safety assessment.","eventGroups":[{"deathsNumAffected":52,"deathsNumAtRisk":108,"description":"Subjects with Relapsed or Refractory CD30 positive Peripheral T-cell Lymphoma (PTCL).","id":"EG000","otherNumAffected":95,"otherNumAtRisk":108,"seriousNumAffected":44,"seriousNumAtRisk":108,"title":"Cohort A"}],"frequencyThreshold":"5","otherEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":13,"numAtRisk":108}],"term":"Constipation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":12,"numAtRisk":108}],"term":"Diarrhoea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":11,"numAtRisk":108}],"term":"Nausea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":11,"numAtRisk":108}],"term":"Abdominal pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":108}],"term":"Vomiting"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":108}],"term":"Dyspepsia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":17,"numAtRisk":108}],"term":"Rash"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":108}],"term":"Erythema"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":108}],"term":"Pruritus"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":16,"numAtRisk":108}],"term":"Anaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":14,"numAtRisk":108}],"term":"Neutropenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":13,"numAtRisk":108}],"term":"Thrombocytopenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":108}],"term":"Lymphopenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":21,"numAtRisk":108}],"term":"Pyrexia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":108}],"term":"Asthenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":108}],"term":"Chills"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":25,"numAtRisk":108}],"term":"Infusion related reaction"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":108}],"term":"Hypokalaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":108}],"term":"Decreased appetite"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":108}],"term":"Hypomagnesaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":108}],"term":"Cough"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":108}],"term":"Dyspnoea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":108}],"term":"Oropharyngeal pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":108}],"term":"Headache"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":108}],"term":"Arthralgia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":108}],"term":"Insomnia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":108}],"term":"Upper respiratory tract infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":108}],"term":"Blood lactate dehydrogenase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":108}],"term":"Respiratory Tract Infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":108}],"term":"Back pain"}],"seriousEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":108}],"term":"COVID-19"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":108}],"term":"Pneumonia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":108}],"term":"Herpes zoster"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":108}],"term":"Septic shock"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":108}],"term":"COVID-19 pneumonia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":108}],"term":"Clostridium difficile colitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":108}],"term":"Cytomegalovirus infection reactivation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":108}],"term":"Enterococcal bacteraemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":108}],"term":"Orchitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":108}],"term":"Periodontitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":108}],"term":"Pneumonia aspiration"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":108}],"term":"Respiratory tract infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":108}],"term":"Rhinovirus infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":108}],"term":"Soft tissue infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":108}],"term":"Staphylococcal sepsis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":108}],"term":"Streptococcal bacteraemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":108}],"term":"Vascular access site infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":108}],"term":"Acute respiratory distress syndrome"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":108}],"term":"Dyspnoea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":108}],"term":"Haemoptysis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":108}],"term":"Pulmonary embolism"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":108}],"term":"Pulmonary haemorrhage"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":108}],"term":"Pulmonary oedema"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":108}],"term":"Infusion related reaction"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":108}],"term":"Pyrexia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":108}],"term":"Chills"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":108}],"term":"General physical health deterioration"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":108}],"term":"Pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":108}],"term":"Acute kidney injury"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":108}],"term":"Acute left ventricular failure"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":108}],"term":"Cardiomyopathy"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":108}],"term":"Hepatic enzyme increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":108}],"term":"International normalised ratio increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":108}],"term":"Dehydration"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":108}],"term":"Hyponatraemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":108}],"term":"Cancer pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":108}],"term":"Diffuse large B-cell lymphoma"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":108}],"term":"Disseminated intravascular coagulation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":108}],"term":"Back pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":108}],"term":"Ischaemic cerebral infarction"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":108}],"term":"Superior vena cava syndrome"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":108}],"term":"Rib Fracture"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":108}],"term":"Bronchitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":108}],"term":"Device Related Sepsis"}],"timeFrame":"From the date of first treatment till the date of the last treatment + 37 days, up to 199 weeks."}